Efficacy and Safety of Vildagliptin in Combination With Pioglitazone in Patients With Type 2 Diabetes

NCT00099853 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

362

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Vildagliptin
DRUG: pioglitazone
DRUG: Placebo

Sponsor

Novartis Pharmaceuticals